Tribune News Service
New Delhi, April 15
As India became the second country after the US to witness two lakh daily Covid cases, the national drug regulator said it would process applications for restricted emergency use from foreign vaccine makers within three working days.
Over 1,700 test +ve at Kumbh mela
Over 1,700 people have tested positive for Covid-19 at the Haridwar Kumbh Mela area from April 10 to 14 confirming fears that one of the world’s largest religious gatherings may contribute further to the rapid rise in cases. PTI
Haryana cancels Class X exam
The Haryana board on Thursday cancelled the Class X exam and postponed those of Class XII
The government has put off the NEET for postgraduate medical admissions which was to be conducted on April 18.
Finalising the regulatory pathway which companies like Pfizer, Moderna and Johnson and Johnson would need to follow, the Central Drug Standard Control Organisation (CDSCO) said applications could be made by the manufacturer through its Indian subsidiary or an authorised agent. Further, applications for registration certificate and import licence will be processed within three working days.
The controller clarified that foreign jabs won’t be included in the national inoculation basket straight away and would need to meet certain conditions.
India’s total tally today reached 1,40,74,564 and active cases soared to 14,71,877.The death toll has risen to 1,73,123 after 1,038 daily fatalities.
On May 5, VijayRaghavan said as the virus mutates further, a...
‘We will not leave people of Karnataka in lurch,’ says a Ben...
‘Punjab requires 2.64 crore doses of the COVID-19 vaccine’
The second wave of the pandemic has led the country begging ...
The ministry has asked the states to contact the company and...